Another also found that Th-17 cells are involved in alcoholic fatty liver disease and can be inhibited by LGGs treatment to facilitate milder steatosis.15 Researchers also previously determined that IL-17 may trigger hepatitis through Th-17 cells and cause hepatocellular carcinoma (Gomes et al., 2016). Here, IL17A is linked to alcoholic fatty liver disease.